2556 |
당뇨병/비만/지질 |
|
Clinical Efficacy of Sodium-Glucose Cotransporter 2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes Mellitus: Real-World Study (Diabetes Metab J 2022;46: 658-62).
|
Hwi Seung Kim |
Diabetes & metabolism journal |
2022/07 |
2555 |
당뇨병/비만/지질 |
|
Advanced Glycation End Products and Their Effect on Vascular Complications in Type 2 Diabetes Mellitus.
|
Jae Seung Yun |
Nutrients |
2022/07 |
2554 |
당뇨병/비만/지질 |
|
Clinical relevance of postoperative proteinuria for prediction of early renal outcomes after kidney transplantation.
|
Jung Eun Lee,Hyun Suk Lee |
Kidney research and clinical practice |
2022/07 |
2553 |
당뇨병/비만/지질 |
|
Community Primary Care-Based Hypertension and Diabetes Management Program in Korea: Evaluation of Participating Patients and Doctors.
|
Park Jae Hyun |
Iranian journal of public health |
2022/07 |
2552 |
당뇨병/비만/지질 |
|
Obesity is an important determinant of severity in newly defined metabolic dysfunction-associated fatty liver disease.
|
Kim Kwang Joon,Byung Wan Lee,Bong Soo Cha,Ji Hye Huh |
Hepatobiliary & pancreatic diseases international : HBPD INT |
2022/06 |
2551 |
당뇨병/비만/지질 |
|
SGLT-2 inhibitors and GLP-1 receptor agonists in metabolic dysfunction-associated fatty liver disease.
|
Soo Lim,Moon Jun Sung,Jun Hwa Hong |
Trends in endocrinology and metabolism: TEM |
2022/06 |
2550 |
당뇨병/비만/지질 |
|
Fimasartan Ameliorates Deteriorations in Glucose Metabolism in a High Glucose State by Regulating Skeletal Muscle and Liver Cells.
|
Kim Hyun Min |
Yonsei medical journal |
2022/06 |
2549 |
당뇨병/비만/지질 |
|
Sodium Glucose Cotransporter-2 Inhibitors as an Add-on Therapy to Metformin Plus Dipeptidyl Peptidase-4 Inhibitor in Patients with Type 2 Diabetes.
|
Kim Young Eun,Yong Ho Lee,Byung Wan Lee,Eun Seok Kang,Bong Soo Cha |
Yonsei medical journal |
2022/06 |